Esophageal cancer linked to osteoporosis drugs

BOSTON (Reuters) – Merck’s popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a Food and Drug Administration official said on Wednesday.

Leave a Reply